non platinum-based chemotherapy for COVID-19 - living meta-analysis of clinical studies

display ongoing

results: demonstrated suggested inconclusive safety concern ongoing study

	breast cancer - HER2-positive	breast cancer - triple negative

	es-BC - HER2 positive - (neo)adjuvant (NA)	mBC - Triple negative (TNBC) - 1st Line (L1)	es-BC - TNBC - NA - all population
non platinum-based chemotherapy
taxanes
paclitaxel
nab-paclitaxel		TORCHLIGHT TORCHLIGHT
paclitaxel followed by doxorubicin plus cyclophosphamide	IMpassion-050 IMpassion-050 IMpassion-050		ALEXANDRA/IMpassion-030

Study type: